Monoclonal antibodies for chronic pain: A practical review of mechanisms and clinical applications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monoclonal antibodies for chronic pain: A practical review of mechanisms and clinical applications
Authors
Keywords
-
Journal
Molecular Pain
Volume 13, Issue -, Pages 174480691774023
Publisher
SAGE Publications
Online
2017-10-23
DOI
10.1177/1744806917740233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calcitonin gene-related peptide and pain: a systematic review
- (2017) Wendy Sophie Schou et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- The role of anti-CGRP antibodies in the pathophysiology of primary headaches
- (2017) Piero Barbanti et al. NEUROLOGICAL SCIENCES
- Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study
- (2017) Hao Wang et al. BMC Urology
- Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study
- (2017) Panna Sanga et al. Arthritis & Rheumatology
- Treatment of chronic low back pain – new approaches on the horizon
- (2017) Nebojsa Nick Knezevic et al. Journal of Pain Research
- Monoclonal antibodies for the treatment of osteoarthritis
- (2016) Shuang Zheng et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tanezumab in the treatment of chronic musculoskeletal conditions
- (2016) Prakash Jayabalan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Anti-CGRP monoclonal antibodies in migraine: current perspectives
- (2016) Maria Adele Giamberardino et al. Internal and Emergency Medicine
- (382) Efficacy, safety, and tolerability of Fulranumab as adjunctive therapy for cancer-related pain: a randomized, double-blind, placebo-controlled, multicenter study
- (2016) N. Slatkin et al. JOURNAL OF PAIN
- Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes
- (2016) J. Curtis Nickel et al. JOURNAL OF UROLOGY
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- New players in the preventive treatment of migraine
- (2015) Dimos D. Mitsikostas et al. BMC Medicine
- Epidermal growth factor receptor – inhibition (EGFR-I) in the treatment of neuropathic pain
- (2015) C. Kersten et al. BRITISH JOURNAL OF ANAESTHESIA
- TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine
- (2015) Sarah Walter et al. Current Pain and Headache Reports
- The Pharmacokinetics of Biologics: A Primer
- (2015) Diane R. Mould DIGESTIVE DISEASES
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Emerging treatments for the primary headache disorders
- (2015) Nathaniel M. Schuster et al. NEUROLOGICAL SCIENCES
- Efficacy and safety of tanezumab in the treatment of pain from bone metastases
- (2015) Maciej Sopata et al. PAIN
- Tumor necrosis factor inhibitor therapy in ankylosing spondylitis
- (2015) Qi Wu et al. PAIN
- Exploring the Role of Tanezumab as a Novel Treatment for the Relief of Neuropathic Pain
- (2015) Candace Bramson et al. PAIN MEDICINE
- Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects
- (2015) Jason M. Gow et al. ARTHRITIS RESEARCH & THERAPY
- Biologics in the Treatment of Chronic Pain: A New Era of Therapy?
- (2015) B Bannwarth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain
- (2014) Thomas J Schnitzer et al. ANNALS OF THE RHEUMATIC DISEASES
- A Monoclonal Antibody that Targets a NaV1.7 Channel Voltage Sensor for Pain and Itch Relief
- (2014) Jun-Ho Lee et al. CELL
- Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
- (2014) Marcelo E. Bigal et al. CNS DRUGS
- Targeting Nerve Growth Factor (NGF) for Pain Management: What Does the Future Hold for NGF Antagonists?
- (2014) Bernard Bannwarth et al. DRUGS
- The therapeutic armamentarium in migraine is quite elderly
- (2014) Paolo Martelletti Expert Opinion on Drug Metabolism & Toxicology
- Ion Channels and Migraine
- (2014) Jin Yan et al. HEADACHE
- Expression of 5-HT3 receptors and TTX resistant sodium channels (NaV1.8) on muscle nerve fibers in pain-free humans and patients with chronic myofascial temporomandibular disorders
- (2014) Nikolaos Christidis et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen
- (2014) E. F. Ekman et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial
- (2014) H. Wang et al. NEUROLOGY
- Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain
- (2014) Joseph S. Gimbel et al. PAIN
- Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee
- (2014) Paul J. Tiseo et al. PAIN
- Clinical Significance of Tumor Necrosis Factor-α Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis
- (2014) Yun Fu Wang et al. PLoS One
- High Prevalence of Neuropathic Pain Features in Patients with Knee Osteoarthritis: A Cross-Sectional Study
- (2014) Ángel Oteo-Álvaro et al. Pain Practice
- Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review
- (2013) Ashley L. Semble et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial
- (2013) Andra Rodica Balanescu et al. ANNALS OF THE RHEUMATIC DISEASES
- Neuropathic Pain in Ankylosing Spondylitis: A Psychophysics and Brain Imaging Study
- (2013) Qi Wu et al. ARTHRITIS AND RHEUMATISM
- Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2013) Mark T. Brown et al. ARTHRITIS AND RHEUMATISM
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Predicting transition to chronic pain
- (2013) A. Vania Apkarian et al. CURRENT OPINION IN NEUROLOGY
- A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor α for sciatica
- (2013) Nefyn H. Williams et al. EUROPEAN SPINE JOURNAL
- Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
- (2013) Marcelo E. Bigal et al. HEADACHE
- Bioanalytical platform comparison using a generic human IgG PK assay format
- (2013) Beth A. Leary et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
- (2013) Egilius L.H. Spierings et al. PAIN
- Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain
- (2013) Panna Sanga et al. PAIN
- Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain
- (2013) Alan J. Kivitz et al. PAIN
- What Is the Evidence that Neuropathic Pain Is Present in Chronic Low Back Pain and Soft Tissue Syndromes? An Evidence-Based Structured Review
- (2013) David A. Fishbain et al. PAIN MEDICINE
- Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model
- (2013) Rui V. Duarte et al. RHEUMATOLOGY INTERNATIONAL
- Report of a Preliminary Discontinued Double-Blind, Randomized, Placebo-Controlled Trial of the Anti-TNF-α Chimeric Monoclonal Antibody Infliximab in Complex Regional Pain Syndrome
- (2013) Maaike Dirckx et al. Pain Practice
- Visceral pain
- (2013) Shafaq Sikandar et al. Current Opinion in Supportive and Palliative Care
- Biologics: the next generation of analgesic drugs?
- (2012) Iain P. Chessell et al. DRUG DISCOVERY TODAY
- Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management
- (2012) Laura McKelvey et al. JOURNAL OF NEUROCHEMISTRY
- Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- (2012) Mark T. Brown et al. JOURNAL OF PAIN
- Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor
- (2012) Joseph K. Eibl et al. NEUROCHEMISTRY INTERNATIONAL
- Single Cycle Structure-Based Humanization of an Anti-Nerve Growth Factor Therapeutic Antibody
- (2012) Sonia Covaceuszach et al. PLoS One
- The transition from acute to chronic pain: might intensive care unit patients be at risk?
- (2012) Maria Kyranou et al. Annals of Intensive Care
- Defining the Differences Between Episodic Migraine and Chronic Migraine
- (2011) Zaza Katsarava et al. Current Pain and Headache Reports
- New targets, new drugs for metastatic bone pain: a new philosophy
- (2011) Francesco Pantano et al. EXPERT OPINION ON EMERGING DRUGS
- Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
- (2011) Ann C. Raddant et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study
- (2011) H. Nagashima et al. OSTEOARTHRITIS AND CARTILAGE
- Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain
- (2011) T.J. Schnitzer et al. OSTEOARTHRITIS AND CARTILAGE
- Efficacy and safety of tanezumab in the treatment of chronic low back pain
- (2011) Nathaniel Katz et al. PAIN
- Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
- (2011) Andreas Hess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attenuation of Inflammatory Events in Human Intervertebral Disc Cells With a Tumor Necrosis Factor Antagonist
- (2011) S. Michael Sinclair et al. SPINE
- Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
- (2010) Jakob Møller Hansen et al. CEPHALALGIA
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- The discovery and development of analgesics: new mechanisms, new modalities
- (2010) Gillian Burgess et al. JOURNAL OF CLINICAL INVESTIGATION
- TNF-α and neuropathic pain - a review
- (2010) Lawrence Leung et al. Journal of Neuroinflammation
- Anti-TNFα Therapy and Control of Chronic Pain in Ankylosing Spondylitis
- (2010) Jadranka Morović-Vergles et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Ziconotide for treatment of severe chronic pain
- (2010) Achim Schmidtko et al. LANCET
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Central sensitization: Implications for the diagnosis and treatment of pain
- (2010) Clifford J. Woolf PAIN
- Challenges in monoclonal antibody-based therapies
- (2009) Haritha Samaranayake et al. ANNALS OF MEDICINE
- Targeting voltage-gated calcium channels for neuropathic pain management
- (2009) Danielle Perret et al. Neurotherapeutics
- Targeting Nerve Growth Factor in Pain
- (2008) Judy J Watson et al. BIODRUGS
- MAP kinase and pain
- (2008) Ru-Rong Ji et al. BRAIN RESEARCH REVIEWS
- Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors
- (2008) Yasmina Noubia Abdiche et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now